Aarti Drugs Ltd.

NSE: AARTIDRUGS | BSE: 524348

Mid-range Performer

Download real time

388.95 9.25 (2.44%)

31.04% Fall from 52W High

216.6K NSE+BSE Volume

NSE 07 Jul, 2026 3:31 PM (IST)

3,549.9

Market Cap

Above industry Median

-

Beta 1Year

Average volatility

Aarti Drugs Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for AARTIDRUGS, BSE:524348 Aarti Drugs Ltd.

Search Inside the pdf :

Aarti Drugs Ltd.

05 Feb 2026

388.95

2.44%

Result Update:Aarti Drugs

buy

Buy: Aarti Drugs Ltd.

Target

Axis Direct

We maintain a BUY with a TP of Rs 480/share, reflecting 29% upside from the CMP

Promoters initiated pledges of 2.47% of holdings in Mar 2026 qtr.

Aarti Drugs Ltd.

11 Nov 2025

388.95

2.44%

Result Update:Aarti Drugs

buy

Buy: Aarti Drugs Ltd.

Target

Axis Direct

We maintain a BUY with a TP of Rs 610/share, reflecting 17% upside from the CMP.

Aarti Drugs Ltd. is trading above its 150 day SMA of 377.5

Aarti Drugs Ltd.

08 May 2025

388.95

2.44%

Result Update:Aarti Drugs

buy

Buy: Aarti Drugs Ltd.

Target

Axis Direct

We maintain our BUY rating on the stock.

Aarti Drugs Ltd. is trading above its 150 day SMA of 377.5

Aarti Drugs Ltd.

30 Jan 2025

388.95

2.44%

Result Update:Aarti Drugs

buy

Buy: Aarti Drugs Ltd.

Target

Axis Direct

We maintain our recommendation of BUY on the stock.

Promoters initiated pledges of 2.47% of holdings in Mar 2026 qtr.

Aarti Drugs Ltd.

29 Oct 2024

388.95

2.44%

Result Update:Aarti Drugs

buy

Buy: Aarti Drugs Ltd.

Target

Axis Direct

We maintain our BUY rating on the stock.

Number of FII/FPI investors decreased from 73 to 64 in Mar 2026 qtr

Aarti Drugs Ltd.

30 Jul 2024

388.95

2.44%

Result Update:Aarti Drugs

buy

Buy: Aarti Drugs Ltd.

Target

Axis Direct

We have BUY on the stock

Promoters initiated pledges of 2.47% of holdings in Mar 2026 qtr.

Aarti Drugs Ltd.

20 May 2024

388.95

2.44%

Pick of the Week:21 MAY 2024

buy

Buy: Aarti Drugs Ltd.

Target

Axis Direct

We recommend a BUY rating on the stock with a target price of Rs 536/share, implying an upside of 10% from CMP

Number of FII/FPI investors decreased from 73 to 64 in Mar 2026 qtr

Aarti Drugs Ltd.

07 May 2024, 12:00AM

388.95

2.44%

Result Update:Aarti Drugs

buy

Buy: Aarti Drugs Ltd.

Axis Direct

Company Outlook & Guidance: In the API sector, a positive shift in the export landscape is anticipated in the near future, supported by interest rate reductions, low stock levels, and an upswing in demand. We have BUY on stock

Promoters initiated pledges of 2.47% of holdings in Mar 2026 qtr.

Aarti Drugs Ltd.

29 Jan 2024

388.95

2.44%

Result Update:Aarti Drugs

buy

Buy: Aarti Drugs Ltd.

Target

Axis Direct

It is expected that API's realisations could be on lower side along elevated key solvents as the industry is facing oversupply.

Aarti Drugs Ltd. is trading above its 150 day SMA of 377.5

Aarti Drugs Ltd.

20 Oct 2023

388.95

2.44%

Result Update:Aarti Drugs

buy

Buy: Aarti Drugs Ltd.

Target

Axis Direct

We expect demand for API to continue in the upcoming quarters with easing supply chain bottlenecks. We believe that Aarti Drugs, being a leader in the domestic industry, is well-placed to capitalize on prevalent as well as future growth opportunities.

Aarti Drugs Ltd. has an average target of 480.00 from 1 broker.

Is Aarti Drugs Ltd. worth buying?

749 Votes:

Buy 77.7%

Sell 11.48%

Hold 10.81%

RESEARCH REPORTS

Buy SEE REPORTS >

Buy SEE REPORTS >